Jim. Thanks,
back of I this incredible to work and are think remarkable everyone but of during ensuring to year we in been first place food on safety industry. the have pandemic, and the in in strategy starting XXXX. for the reflect As roots we agricultural a tenacity the in by creativity six privilege achieved I The of our customers them. supply. thanked support our be taken in help done the year, in our first-half the this their commercial results can't put It's months It's
internal international our extending the BioUnite we as by: showed next new our third, growth and portfolio, like come our If and first, such These products. including insecticide the you creation Pro value pipeline, acquisitions presence, Slide that our analysis program, unlock with nematicide. driving and second, X, of material from accelerating advance generation Farm, could to by expanding may of through growth our the turn treatment accretive would seed reach or existing
and opportunities to grow chemistry, biology or have as as lower will performance either well of existing expand We first base also the business remains the goods our in increased markets. cost that further BioUnite market manufacturing market share or cornerstone is which through of The penetration. improvement formulation new strategy, ability power combines with I thriving, the brand the of that and of through extensions, share. note
represents of crops our in cover Our portfolio sales. projected roughly crop of products annual and specialty bioprotection two-thirds
our We that countries. anticipate the will change But sales from roughly of and in with last year, international strategy XX this coming first-half including biggest year. A We is the global full new XX with seed year, reflects to full that pillar Latin of in growth international is by presence, America. XX% range, last treatment greater and to have Europe seen work This our is a distributors This expanding more the in Over U.S., XX% both year. it to the of end mix breadth international. shift distribution XX-XX and worldwide, now business. XX% cornerstone than U.S. grow strategy our split compares we our outside agreement second our depth. first-half year A the
The you have a to and Farm Sales revenues Latin to largest including program the as component initial tracking success, year, net in Farm in Pro an major Slide in been some income market. Overall, quarter strong, operations second of there regions, to as has If from of tap the we that would and world's to had in be is U.S. the forecasted. this begin XX. this and later trial Pro this acquisition we Europe were year, we is aggressive cash turn with underway accretive growing will America
such the of testing soybean we cereal demonstration, At treatment The trials in Brazil, Out with into insecticide anticipate reaching between corn. crops, nematicide as acquisition, we're grains. of UBP just Pro XX synergies beyond potential Additionally, is play total our cross-selling corn portfolios. to for time out. and and Farm’s starting the our combined are canola and seed other in the
successful are opportunities. part growth introductions mid-term any both and near we advancing New have product of to be and strategy,
be internal our manufacturing in Europe, have offer year. growers' both regulatory two we range for and and nematicide. performance methods, a in the productivity trials field in been insecticide such from strong of in-furrow application candidates They United And will test testing seed of applied market potential reach. plan are which Both near-term We improve submissions, we Latin as additional and prepare and are possible. have both can our of generation treatment. pipeline, next second-half the America Initial in to the States of foliar, as enhanced across and
advancing the invest major Slide While work, our the the out, in crop our EPA pipeline, little row gain row shown roughly this and field also opportunity further approval. we bioherbicide of growth our to is those MBI-XXX/XXX, is portfolio become necessary We one-third our with markets continue year. of a part crop XX. on and noble to sales will a testing, the packages story, formulation and our markets Across as well key as the believe market of projected represent have size regulatory
It's working new trials across health product. It's health. a our plant States. tested with integrated entry used is that and on lead product opportunity adoption have EPA Last ease the market. summer tank for conventional we approval and product we're portfolio, summary, to in the of is proof which this fungicide fungicide strategy the It choice. soybean in use the Pacesetter wheat. XX announced into the emergent approved, for ever will is and Pro entry sell offerings. containing industry. market biologicals being growth implementing expands our and fronts. We combination Regalia. premix full for crops. in and exclusive premix will which have in the been will are is an foliar ability in a commercial This new year applied partner United mixed ingredients synergistic with we our program progress hits week, our [ph] Once Pacesetter, immediate are active U.S. plant row that our Vive, multiple market, offering, be pest in growers other in with in of with It we available management our another the opportunity strategy in seeking corn, BioUnite California commercial the that farms. an delivering, a into or and a our In it products the Pacesetter this BioUnite to Farm with we're BioUnite It's first has is with rights improve
results agriculture. pandemic, quarter's shifting were market the by uncertain This delivered created and across headwinds despite international trade global environment, a dynamics and
to bring world. the and remarks, globally, footprint questions. turn back to row of finished are we to about his Kevin the the business, the continue optimistic our call in expand for closing the to the our now we grow tools productivity crops open second-half particularly As growers like ability year, base call to before I'd we to around Helash